Objective: The objective of our study was to compare the image quality and radiation dose of computed tomography pulmonary angiography (CTPA) in patients with different body mass indexes using 100-kVp combination of different noise indexes (NIs) and 120-kVp scan protocol with the adaptive statistical iterative reconstruction 2.0 algorithm (ASiR 2.0).
Methods: A total of 120 patients who had undergone a CTPA were divided into 4 groups (A, B, C, and D), with 30 patients in each group. Group A underwent 120-kVp CT scan protocol in combination with NI = 25, while groups B, C, and D underwent 100-kVp CT scan protocol in combination with NI = 30, 35, and 40, respectively. All images were restructured using ASiR 2.0. The signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) of all images were calculated when the CTPA was completed. Each subjective image evaluation used a 5-point scoring method and was conducted by 2 independent radiologists. The CT dose index of volume and dose-length product were recorded, and the mean value was calculated. The dose-length product was converted to the effective dose.
Results: There were no significant differences in SNR, CNR, and subjective image quality among the groups A, B, C, and D. The effective dose of group D decreased by 48.33% and 27.27% relative to groups A and B, respectively (P < 0.01).
Conclusions: The 100-kVp CT scan protocol in combination with NI = 40 can more effectively reduce the radiation dose than can the 120-kVp CT scan protocol in combination with NI = 25 for a CTPA while still maintaining diagnostic image quality.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/RCT.0000000000000488 | DOI Listing |
Rare Tumors
January 2025
Internal Medicine Department, An Najah National University Hospital, Nablus, Palestine.
Ewing sarcoma family tumors (ESFT) pose diagnostic challenges, which largely depend on the primary site of involvement and tumor stage. Despite advancements in treatment, metastatic ESFTs remain associated with poor outcomes. This case describes a 21-year-old woman who, in July 2022, presented with a left breast mass identified through ultrasound and CT scan, along with abdominal distention.
View Article and Find Full Text PDFIndian J Nucl Med
November 2024
Department of Nuclear Medicine and Molecular Imaging, Homi Bhabha Cancer Hospital & Mahamana Pandit Madan Mohan Malaviya Cancer Centre, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Varanasi, India.
Background: The introduction of positron emission tomography/computed tomography (PET/CT) has significantly advanced medical imaging. In oncology, F-fluorodeoxyglucose (F-FDG) PET/CT is particularly crucial for staging, evaluating treatment response, monitoring follow-up, and planning radiotherapy. However, in resource limiting hospitals, the availability of fluorine-labeled F-FDG limits optimal scan acquisition.
View Article and Find Full Text PDFEur Radiol
January 2025
Department of Diagnostic and Interventional Radiology, University Hospital Augsburg, Augsburg, Germany.
Objectives: The purpose of this study was to evaluate whether the iodine contrast in blood and solid organs differs between men and women and to evaluate the effect of BMI, height, weight, and blood volume (BV) on sex-specific contrast in staging CT.
Materials And Methods: Patients receiving a venous-phase thoracoabdominal Photon-Counting Detector CT (PCD-CT) scan with 100- or 120-mL CM between 08/2021 and 01/2022 were retrospectively included in this single-center study. Image analysis was performed by measuring iodine contrast in the liver, portal vein, spleen, left atrium, left ventricle, pulmonary trunk, ascending and descending aorta on spectral PCD-CT datasets.
Background: New generation PET scanners achieve superior resolution and sensitivity, but the implications on beta amyloid (Aβ) quantitation are not well understood. The Centiloid (CL) scale (Klunk et al., 2015) was introduced to promote consistent Aβ burden quantification across different positron emission tomography (PET) tracers and quantification pipelines, but was not intended to control for hardware or reconstruction changes.
View Article and Find Full Text PDFBackground: Phase four of the Alzheimer's Disease Neuroimaging Initiative (ADNI4) began in 2023. This time-period corresponded to MRI vendors introducing product sequences with compressed sensing (CS), cross-vendor adoption of arterial spin-labelling (ASL) and multi-band slice excitation, and hardware improvements (head-coils, increased gradient amplitudes). These advances enabled the acquisition of new imaging measures and reduced scan times.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!